DS
IMMX icon

David Shaw’s Immix Biopharma IMMX Stock Holding History

David Shaw’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$960K Buy
+93,106
New +$864K ﹤0.01% 3775

Other funds holding IMMX

JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

David Shaw's IMMX Position: Q2 2026 in Review

David Shaw opened a new position in Immix Biopharma (IMMX) in Q2 2026: 93,106 shares worth $960K. The stake represents ﹤0.01% of the portfolio and ranks #3775 among its holdings.

108 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • David Shaw held 93,106 shares of Immix Biopharma worth $960K as of Q2 2026.
  • Immix Biopharma was a new David Shaw position in Q2 2026.
  • Immix Biopharma made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3775 holding.
  • 108 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.